Keyphrases
Screening Mammography
90%
Progressive Supranuclear Palsy
90%
Musculoskeletal Ultrasound
90%
Breast Cancer
90%
Wellness Curriculum
90%
Cancer Screening Recommendations
90%
Diagnostic Accuracy
90%
Dementia with Lewy Bodies
90%
Potential Impact
90%
Ultrasound-guided Intervention
90%
US Preventive Services Task Force (USPSTF)
90%
Breast Cancer Screening
90%
Neurovascular Unit
90%
Specific Imaging
90%
Neurodegenerative
90%
American Cancer Society
90%
Cancer Detection Rate
74%
Ultrasound
60%
Disease Course
45%
Synucleinopathy
45%
Most Common Cause
45%
Disease-modifying Therapy
45%
Pathophysiology
45%
Therapeutic Imaging
45%
Vascular Dementia
45%
PET Imaging
45%
Etiology
45%
Dopamine Transporter
45%
Lewy Pathology
45%
Screen-detected Cancer
45%
Single-photon Emission Computed Tomography (SPECT)
45%
Diagnostic Work-up
45%
Therapeutic Considerations
45%
Alternative Diagnosis
45%
Causes of Dementia
45%
18F-fluorodeoxyglucose Positron Emission Tomography (18F-FDG PET)
45%
4R-tauopathy
45%
PET Tracer
45%
Early Diagnosis
45%
Alzheimer's Dementia
45%
Structural Magnetic Resonance Imaging (sMRI)
45%
Atypical Parkinsonian Syndromes
45%
123I
45%
Therapeutic Goals
45%
Disease Pathophysiology
45%
Disease Characterization
45%
Imaging Biomarkers
45%
Therapeutic Agents
45%
Radiation Exposure
29%
Routine Operations
29%
Medicine and Dentistry
Radiology
100%
Breast Cancer
90%
Breast Cancer Screening
90%
Mammography
90%
Interventional Ultrasonography
90%
Wellbeing
90%
Iatrogenesis
90%
Radiation Exposure
90%
Malignant Neoplasm
90%
Postsynaptic Potential
90%
Regional Anatomy
90%
Diffuse Lewy Body Disease
90%
Progressive Supranuclear Palsy
90%
Pathophysiology
74%
Disease
74%
Diagnostic Accuracy
60%
Positron Emission Tomography
60%
Tau
60%
Cancer Diagnosis
50%
Alzheimer's Disease
45%
Lewy Body
45%
Vascular Dementia
45%
Burnout
45%
Early Diagnosis
45%
Synucleinopathies
45%
Biopsy
39%
Single-Photon Emission Computed Tomography
29%
Tauopathy
29%
Iodine 123
29%
Parkinsonism
29%
Diagnosis
29%
Biological Marker
29%
Hope
29%
Disease Course
29%
Dopamine Transporter
29%
Fluorodeoxyglucose F 18
29%
Positron Emission Tomography
29%
Therapeutic Agent
29%
Radioactive Tracer
29%
Structural Imaging
29%
Emotional Stress
18%
Depersonalization
18%
BRCA Mutation
9%
Retrospective Cohort Study
9%
